As of 2026-04-21, the Relative Valuation of Exact Sciences Corp (EXAS) is (11.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 104.91 USD, the upside of Exact Sciences Corp based on Relative Valuation is -111.1%.
The range of the Relative Valuation is (10.00) - (12.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 11.6x | 9.2x |
| Forward P/E multiples | 9.2x - 17.7x | 12.2x |
| Fair Price | (10.00) - (12.59) | (11.66) |
| Upside | -109.5% - -112.0% | -111.1% |
| Date | P/E |
| 2026-03-20 | -96.30 |
| 2026-03-19 | -95.39 |
| 2026-03-18 | -95.24 |
| 2026-03-17 | -95.41 |
| 2026-03-16 | -95.33 |
| 2026-03-13 | -95.07 |
| 2026-03-12 | -94.80 |
| 2026-03-11 | -94.92 |
| 2026-03-10 | -94.89 |
| 2026-03-09 | -95.20 |
| 2026-03-06 | -95.01 |
| 2026-03-05 | -94.84 |
| 2026-03-04 | -95.01 |
| 2026-03-03 | -94.89 |
| 2026-03-02 | -94.87 |
| 2026-02-27 | -94.90 |
| 2026-02-26 | -94.78 |
| 2026-02-25 | -94.80 |
| 2026-02-24 | -94.96 |
| 2026-02-23 | -94.91 |
| 2026-02-20 | -94.95 |
| 2026-02-19 | -94.82 |
| 2026-02-18 | -94.88 |
| 2026-02-17 | -94.84 |
| 2026-02-13 | -94.77 |
| 2026-02-12 | -94.76 |
| 2026-02-11 | -94.95 |
| 2026-02-10 | -94.87 |
| 2026-02-09 | -94.84 |
| 2026-02-06 | -94.72 |
| 2026-02-05 | -94.24 |
| 2026-02-04 | -93.88 |
| 2026-02-03 | -94.10 |
| 2026-02-02 | -94.09 |
| 2026-01-30 | -93.94 |
| 2026-01-29 | -93.91 |
| 2026-01-28 | -93.86 |
| 2026-01-27 | -93.94 |
| 2026-01-26 | -94.10 |
| 2026-01-23 | -93.87 |
| 2026-01-22 | -93.97 |